Beijing Science Sun Pharmaceutical Co Ltd
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, among others. It is also involved in the research, development, production, and sale of raw materials; the extraction of traditional Chin… Read more
Beijing Science Sun Pharmaceutical Co Ltd (300485) - Total Liabilities
Latest total liabilities as of September 2025: CN¥171.26 Million CNY
Based on the latest financial reports, Beijing Science Sun Pharmaceutical Co Ltd (300485) has total liabilities worth CN¥171.26 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Beijing Science Sun Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Beijing Science Sun Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Beijing Science Sun Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Science Sun Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Xiantong Rubber&Plastic Co Ltd
SHG:603239
|
China | CN¥400.42 Million |
|
Infibeam Avenues Limited
NSE:INFIBEAM
|
India | ₹18.71 Billion |
|
Frey SA
PA:FREY
|
France | €2.07 Billion |
|
Dongjiang Environmental Company Limited
PINK:SZDEF
|
USA | $7.24 Billion |
|
Versamet Royalties Corporation
TO:VMET
|
Canada | CA$182.03 Million |
|
Dalian Haosen Equipment Manufacturing Co. Ltd. A
SHG:688529
|
China | CN¥5.27 Billion |
|
Changzhou Almaden Co Ltd
SHE:002623
|
China | CN¥2.87 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Beijing Science Sun Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 21.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Science Sun Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual total liabilities of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥166.48 Million | +7.68% |
| 2023-12-31 | CN¥154.61 Million | -1.58% |
| 2022-12-31 | CN¥157.10 Million | +32.52% |
| 2021-12-31 | CN¥118.54 Million | -16.00% |
| 2020-12-31 | CN¥141.13 Million | +49.73% |
| 2019-12-31 | CN¥94.26 Million | -54.04% |
| 2018-12-31 | CN¥205.07 Million | +53.14% |
| 2017-12-31 | CN¥133.91 Million | +12.88% |
| 2016-12-31 | CN¥118.63 Million | +91.34% |
| 2015-12-31 | CN¥62.00 Million | -13.54% |
| 2014-12-31 | CN¥71.71 Million | +51.51% |
| 2013-12-31 | CN¥47.33 Million | +34.56% |
| 2012-12-31 | CN¥35.18 Million | +8.59% |
| 2011-12-31 | CN¥32.39 Million | -- |